Sugi Predict

Sugi Predict / Compounds / SCHEMBL949228

SCHEMBL949228

SCHEMBL949228

C#Cc1ccc(OCCCCC)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR5A1 Q13285 1/20 0.58
▸ LTA4H P09960 5/20 0.56
▸ TP53 P04637 2/20 0.51
▸ TSHR P16473 1/20 0.51
▸ PLA2G4B P0C869 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ LMNA P02545 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ RARB P10826 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748828 0.98 NR5A1 (0.61) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL948700 0.98 NR5A1 (0.61) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL3924421 0.98 NR5A1 (0.61) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL946779 0.98 NR5A1 (0.61) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL9706419 0.98 NR5A1 (0.61) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL2832393 0.98 NR5A1 (0.61) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL1007565 0.96 LTA4H (0.53) NR5A1LTA4HTP53TSHRNPC1
SCHEMBL10987443 0.94 CYP2D6 (0.56) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL10987211 0.93 RARB (0.58) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL7697232 0.93 RARB (0.58) NR5A1LTA4HTP53TSHRPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104479771-B Suppress the composition that boiler alcohol-group fuel nitrogen oxide generates SHANXI HUADUN INDUSTRY CO., LTD. (CN) 2016-05-04 — — CN claimed
CN-104479771-A Composition for inhibiting alcohol-based fuel for boilers from producing nitrogen oxides SHANXI WHARTON IND CO LTD 2015-04-01 — — CN claimed
US-20250122132-A1 NITRIFICATION INHIBITORS LINCOLN UNIVERSITY (NZ) 2025-04-17 — — US disclosed
US-20250011365-A1 ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shenzhen Sungening Biological Co., Ltd (CN) 2025-01-09 — — US disclosed
CN-118388306-A M-terphenyl derivative and synthesis method thereof 湖南大学 2024-07-26 — — CN disclosed
US-20230202941-A1 NITRIFICATION INHIBITORS LINCOLN UNIVERSITY (NZ) 2023-06-29 — — US disclosed
US-20230202941-A1 NITRIFICATION INHIBITORS LINCOLN UNIVERSITY (NZ) 2023-06-29 — — US disclosed
US-11578013-B2 Nitrification inhibitors LINCOLN UNIVERSITY (NZ) 2023-02-14 — — US disclosed
US-11578013-B2 Nitrification inhibitors LINCOLN UNIVERSITY (NZ) 2023-02-14 — — US disclosed
CN-110563531-B Synthetic method of 1, 2-disubstituted olefin compound 浙江工业大学 2022-06-21 — — CN disclosed
US-20220153655-A1 NITRIFICATION INHIBITORS LINCOLN UNIVERSITY (NZ) 2022-05-19 — — US disclosed
EP-0941236-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-09-15 — — EP disclosed
WO-1998023637-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-04 — — WO disclosed
CN-1168675-A Novel compounds FUJISAWA PHARMACEUTICAL CO (JP) 1997-12-24 — — CN disclosed
EP-0788511-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-13 — — EP disclosed
WO-1996011210-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-18 — — WO disclosed
EP-0367771-B1 ARYL SULPHUR PENTAFLUORIDES MERCK PATENT GmbH (DE) 1992-09-02 — — EP disclosed
US-5055223-A For use in liquid crystal display elements MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1991-10-08 — — US disclosed
EP-0367771-A1 ARYL SULPHUR PENTAFLUORIDES. MERCK PATENT GMBH (DE) 1990-05-16 — — EP disclosed
WO-1988010251-A1 ARYL SULPHUR PENTAFLUORIDES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1988-12-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202941-A1 NITRIFICATION INHIBITORS NOS1, NOS2, NOS3 NR5A1 1175/4885LTA4H 1580/4885TP53 4094/4885
US-11578013-B2 Nitrification inhibitors NOS1, NOS2, NOS3 NR5A1 1175/4885LTA4H 1580/4885TP53 4094/4885
US-20250122132-A1 NITRIFICATION INHIBITORS NOS1, NOS2, NOS3 NR5A1 1175/4885LTA4H 1580/4885TP53 4094/4885
US-20220153655-A1 NITRIFICATION INHIBITORS NOS1, NOS2, NOS3 NR5A1 1175/4885LTA4H 1580/4885TP53 4094/4885
US-20250011365-A1 ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF CYP51A1, ERG28, WEE1 NR5A1 96/4885LTA4H 557/4885TP53 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.